Recent Updates
Recently added Catalysts
RVMD Neutral Sentiment

Revolution Medicines to Report Financial Results for Fourth Quarter and Full Year 2025 After Market Close on February 25, 2026

Wednesday, February 18, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Revolution Medicines, Inc. has announced that it will report its financial results for the fourth quarter and full year of 2025 on February 25, 2026, after market close. The announcement highlights that a webcast hosted by the senior management team will take place at 4:30 p.m. ET to discuss the results and provide updates on corporate progress. Interested parties can access the live event and a replay afterward on the company's website.
Price reaction · baseline $100.61 (2026-02-17 close) · hit after-hours · clean, no other RVMD news in the window
day 0 close · peak
-0.8%

Market Sentiment Analysis

POSITIVE FACTORS

  • The company is set to report financial results, indicating ongoing business activity.
  • Senior management will provide a corporate progress update during the webcast.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+124%
120-day peak, hindsight
Typical move
6.7%
average across 3 past catalysts
Cash runway
~30 mo
Minimal dilution risk
Lead asset
daraxonrasib
Phase 3 · NSCLC (Non-small Cell Lung Cancer)

Full Press Release Details

REDWOOD CITY, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced that it will report financial results for the fourth quarter and full year 2025 on Wednesday, February 25, 2026, after market close. At 4:30 p.m. ET that day (1:30 p.m. PT), members of Revolution Medicines’ senior management team will host a webcast to discuss the financial results for the quarter and full year, and provide an update on corporate progress.
To listen to the live webcast, or access the archived webcast, please visit: https://ir.revmed.com/events-and-presentations. Following the live webcast, a replay will be available on the company’s website for at least 14 days.
About Revolution Medicines, Inc.
Revolution Medicines Media & Investor Contact:

Frequently Asked Questions

When will Revolution Medicines report its financial results for 2025?

Revolution Medicines will announce its financial results on February 25, 2026.

What time is the webcast for the financial results update?

The webcast is scheduled for 4:30 p.m. ET on February 25, 2026.

How can I access the live webcast?

You can access the live webcast at https://ir.revmed.com/events-and-presentations.

Will there be a replay of the webcast?

Yes, a replay will be available for at least 14 days after the webcast.

Who should I contact for media inquiries?

For media inquiries, contact Revolution Medicines at investors@revmed.com.

ShareAdd on Google
Tags: RVMD Viatris Investor Conferences Healthcare Revolution Medicines Q4 2025 financial results oncology
Last updated: Feb 18, 2026

Biotech snapshot

Cash runway
$3938M liquidity · $129M/mo burn
~30 mo
Minimal dilution risk
Lead asset
daraxonrasibPhase 3
NSCLC (Non-small Cell Lung Cancer) →

Catalyst track record

+124%
best trade around RVMD's most recent catalyst

Peak hindsight return over a 120-day window, across 3 tracked FDA/PDUFA catalysts for RVMD.

See every catalyst's timing & PoA →